Related Experiment Videos
Protein AA in primary and myeloma associated amyloidosis
Abstract:
Protein AA, the main fibril constituent in secondary systemic amyloidosis, was demonstrated by the peroxidase-anti-peroxidase method in kidney sections from five out of 14 cases of primary and myeloma associated amyloidosis, all having an immunoglobulin light chain derived protein as a major subunit. In three of these cases, protein AA was also demonstrated in double immunodiffusion of dissolved amyloid preparations. The protein had the characteristics of protein AA in elution position, immunodiffusion and isoelectric focussing pattern. The significance of protein AA in primary and myeloma associated amyloidosis is unknown.
Insights
Researchers detected Protein AA, a key component of secondary systemic amyloidosis, in kidney samples from patients with primary and myeloma-associated amyloidosis. Its presence and significance in these conditions require further investigation.
Area of Science:
- Biochemistry
- Immunology
- Pathology
Background:
- Secondary systemic amyloidosis is characterized by Protein AA fibrils.
- Primary and myeloma-associated amyloidosis typically involve immunoglobulin light chains.
Purpose of the Study:
- To investigate the presence and characteristics of Protein AA in primary and myeloma-associated amyloidosis.
- To determine if Protein AA is a component in these amyloidosis subtypes.
Main Methods:
- Peroxidase-anti-peroxidase (PAP) method for kidney section analysis.
- Double immunodiffusion assay for dissolved amyloid preparations.
- Isoelectric focusing for protein characterization.
Main Results:
- Protein AA was detected in kidney sections of 5 out of 14 patients with primary or myeloma-associated amyloidosis.
- Protein AA was confirmed in dissolved amyloid preparations from 3 of these patients.
- The identified protein exhibited characteristics consistent with Protein AA.
Conclusions:
- Protein AA can be present in primary and myeloma-associated amyloidosis.
- The role and significance of Protein AA in these specific amyloidosis types remain undetermined.